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during cranium, head and neck, thorax and prostate imaging 
using PCXMC, a Monte Carlo computer program. The organ 
doses will be compared with published organ doses resulting 
from cone-beam CT and MV planar imaging. 
Materials and Methods: The half-value layer, total filtration, 
radiation output and peak kilovoltage of the x-ray beams 
were measured using an Unfors Xi meter. Entrance dose, 
entrance field-size and focus to skin distance were calculated 
for each clinical protocol and used as input to PCXMC 
simulations. Clinically-representative beam directions and 
angles were used. Absorbed dose to each simulated organ 
and effective dose were calculated from a pair of ExacTrac 
exposures for each anatomical protocol. 
Results: The maximum organ dose was 0.4 mGy to the 
kidneys from the prostate protocol. The maximum effective 
dose of 0.1 mSv was also from the prostate protocol. The 
maximum organ dose from a pair of ExacTrac images is 
between 27 and 128 times lower than published organ doses 
resulting from a single cone-beam computed tomography 
scan, and 250 times lower than doses from a single MV 
planar-imaging procedure published in the literature. 
Conclusions: This study has shown that PCXMC can be used to 
estimate organ and effective doses from ExacTrac use. Organ 
doses from ExacTrac are low compared with those from cone-
beam CT and MV planar-imaging. 
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Purpose/Objective: The presence of dental implants or 
fillings affects the image quality of the planning-CT (pCT) of 
head and neck (H&N) patients by causing scatter and beam 
hardening artifacts. These artifacts can cause inaccuracies in 
the dose calculation of the radiation therapy treatment plan, 
in particular if a deterministic dose calculation algorithm is 
used (Acuros XB [AXB; Varian Medical Systems Inc., Palo Alto, 
USA]).  
A recent commercially released CT reconstruction algorithm 
(MAR; General Electric, Milwaukee, USA) greatly reduces 
metal artifacts and thus hypothetically improves the 
accuracy of the dose calculation for patients with dental 
fillings or implants. 
Applying a density override (DO) for the scatter regions is 
another often used solution to reduce the influence of metal 
artifacts on the dose calculation. We studied the effect of 
density overrides, the use of MAR and the combination of 
both on the dose distribution for H&N cancer patients with 
dental fillings treated with RapidArc (RA) radiotherapy. 
Materials and Methods: For five H&N cancer patients with 
dental implants and/or fillings near the location of the tumor 
an additional MAR-CT reconstruction was acquired after the 
pCT was obtained. For each patient 4 different datasets were 
generated: 1)pCT without DO; 2)pCT with DO; 3)MAR-CT 
without DO; 4)MAR-CT with DO. Dataset 4 was used as the 
reference dataset. For each dataset a treatment plan was 
created using our standard clinical optimization protocol and 
calculated on the reference dataset using AXB. 
For all plans DVH parameters (Dmax, Dmean, D2%, D98% and the 
V95%) for PTVboost and PTVscatter, which represents only that part 
of the PTVboost which is affected by scatter, were reported 
and compared to those of the reference dataset. Also, 
differences in dose to the OAR, the ipsi- and contra-lateral 
parotid gland and the contra-lateral submandibular gland 
were reported in terms of Dmax, Dmean and D2%. 
Results: Preliminary results for 1 patient show limited 
differences in PTV coverage between the 3 datasets and the 
reference dataset. The Dmax of the PTVboost differed 1% at 
most, and the PTVscatter shows an increase in Dmax of 1.4% for 
the treatment plan based on the pCT without DO (Table 1, 
Figure 1). Larger differences were found for the OAR’s. The 
Dmean of the contralateral submandibular gland was found to 
be 47 cGy, 90 cGy and 170 cGy higher for dataset 3, 1 and 2 
respectively. 
 
Table 1: Dose information pCT without DO and percentage 
difference compared to MAR-CT with DO 
 
 
Figure 1: Planning-CT (left) and MAR-CT reconstruction (right) 
visualized with the contoured GTV (blue) , CTVboost (green) 
and PTVboost (red) , and both parotid glands (purple and lime).  
 
Conclusions: Although there is an increase in mean dose of 
the OAR’s when MAR, a density override or a combination of 
both is omitted, the differences in dose distribution between 
the several methods are small and not clinically relevant. 
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Purpose/Objective: The objective of the ARTFiBio project is 
to establish an integrated information network from which 
they can develop predictive models of tumour response based 
on functional data in vivo and to share datasets, and 
registration and predictive tools with the scientific 
community. 
In order to relate information from multiple imaging 
modalities ( PET, CT y MRI) at different stages of treatment 
(through time) a robust registration scheme is critical. We 
present results of a comparison ARTFIBio tools with the 
